ACRA AKRO
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.26B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.05B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.56
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

59.31M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events

All events
No upcoming events scheduled

Stock chart

Stock analysis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-7.02 -
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

2.35 3.92
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-5.14 -
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

1.02 -
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-21.18 -

Price change per year

17.66$ 34.87$
Min Max

Summary analysis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure

Revenue and net income

All parameters

Stock news

All news

Минфин РФ видит рост интереса россиян к получению госуслуг в негосударственном секторе

$1.8K to stand in line: Line sitters are cashing in on Donald Trump's hush-money trial, reports say

Опцию обычного оформления сим-карт нужно сохранить при повышении безопасности - Минцифры

Two House Republicans are dating. Here are four other couples who have dated — or married — while in Congress.

Объем производства автомобилей VGV в Белоруссии может составить до 30 тыс. машин в год

В РФ могут создать единую платформу видеонаблюдения

Рабочая группа проработает вопрос создания единой платформы противодействия мошенничеству

Поврежденный в Красном море танкер недавно останавливался в РФ - командование ВС США

Допинвестиции ИТ-компаний из РФ в разработку ПО к 2030 году составят 174 млрд руб.

Суд РФ арестовал активы Commerzbank по иску Русхимальянса

Тестовые зоны 5G до 2030 года появятся во всех субъектах РФ - Минцифры

Суд РФ наложил арест на активы, счета и имущество Commerzbank по иску "Русхимальянса"

СУД РФ НАЛОЖИЛ АРЕСТ НА АКТИВЫ, СЧЕТА И ИМУЩЕСТВО COMMERZBANK ПО ИСКУ "РУСХИМАЛЬЯНСА" - КАРТОТЕКА

Минфин: российские инвесторы открыли более 110 тыс. новых ИИС

Развитие химической промышленности критически важно для роста ВВП РФ - депутат

About company

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Address:
601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Company name:
Issuer ticker: AKRO
ISIN: US00973Y1082
Country: USA
Exchange: ACRA
Currency: $
IPO date: 2019-06-20
Sector: Healthcare
Industry: Biotechnology
Site: https://www.akerotx.com

On which stock exchange are (AKRO) stocks traded?

(AKRO) stocks are traded on ACRA.

What is the ticker of stocks (AKRO)?

The stock ticker of ’s stocks or in other words, the code is AKRO. The stocks are currently listed on the ACRA exchange.

In which sector and industry does (AKRO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, (AKRO) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are (AKRO) stocks traded?

(AKRO) stocks are traded on the ACRA exchange in dollars.

What is the price of (AKRO) stocks today?

The current price of stocks on 19.05.2024 is dollars. per share.

What is the dynamics of (AKRO) stocks from the beginning of the year?

(AKRO) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did (AKRO) stocks increase in мае 2024?

This month (AKRO) quotes have increased by 0% to dollars. per share.

How much are (AKRO) stocks worth?

Today, on October, 19.05.2024 ’s (AKRO) stocks cost dollars..

What is the market capitalization of (AKRO)?

Capitalization is the market value of (AKRO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of (AKRO) is estimated at about 1258510646 dollars.